TP53 and hepatocellular carcinoma: Moreover, the mutation co‐occurrence between TP53 and other genes, such as TTN, MUC16, and CTNNB1, was more frequent in HCC CAG cluster 2 (Fig. S2D–F) than in the other clusters.